GeNO

Takeda joins SGC, funds drug research

Friday, April 6, 2012 11:34 AM

Takeda Pharmaceutical has joined the Structural Genomics Consortium (SGC), based at the Universities of Toronto and Oxford, England, to fund collective drug research aimed at bringing new, more effective medicines to market faster.

More... »


1000 Genomes Project data available on Amazon Cloud

Monday, April 2, 2012 02:51 PM

The world's largest set of data on human genetic variation — produced by the international 1000 Genomes Project — is now publicly available on the Amazon Web Services (AWS) cloud, the according to the National Institutes of Health (NIH).

More... »


Sanofi to collaborate with the Center for Genomic Regulation

Friday, March 9, 2012 02:21 PM

The Center for Genomic Regulation (CRG), an international biomedical research institute of excellence supported by the Catalan government and the Spanish Ministry of Science and Innovation, has entered a research collaboration with Sanofi to share research programs using state-of-the-art experimental platforms and computational and bioinformatics approaches, in computational biology, medical genetics and epigenetics, with special emphasis in genetic and rare diseases.

More... »

Complete Genomics to provide whole genome sequencing to Mayo Clinic

Friday, February 17, 2012 01:44 PM

Complete Genomics has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing.

More... »

Trovagene names new vice president

Friday, February 17, 2012 12:46 PM

Trovagene, a developer of transrenal molecular diagnostics, has named Charlie Rodi, Ph.D., vice president and chief technology officer.

More... »

Broad Institute joins Illumina Genome Network

Thursday, February 16, 2012 06:22 AM

The Broad Institute has joined the Illumina Genome Network (IGN) to offer its proprietary sample preparation processes for whole human genome sequencing.

More... »

EntreMed names two to board of directors

Tuesday, February 7, 2012 01:07 PM

EntreMed, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, has appointed Wei-Wu He, Ph.D, executive chairman of its board of directors, and Tak W. Mak, Ph.D, as member of the board of directors.

More... »

Pinpoint Genomics publishes Dx Lung assay data

Tuesday, January 31, 2012 09:38 AM

Pinpoint Genomics has published key data relating to its Pinpoint Dx Lung assay in the journal The Lancet, and has made the assay available to clinicians and patients exclusively through the company's laboratory in Mountain View, Calif.

More... »

GeNO doubles executive management team

Friday, January 20, 2012 03:01 PM

GeNO, a privately held technology company, has hired four new senior executives and promoted two others, more than doubling its executive management team.

More... »

HGS’s Benlysta grosses $59 million

Wednesday, January 11, 2012 11:05 AM

Benlysta (belimumab), the first approved drug for systemic lupus in 56 years, has already grossed $59.2 million, averaging $2.3 million in sales per week since it received FDA approval less than a year ago, according to Human Genome Sciences (HGS).

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs